Tissue attenuation imaging and tissue scatter imaging for quantitative ultrasound evaluation of hepatic steatosis

13Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We aimed to assess the feasibility of ultrasound-based tissue attenuation imaging (TAI) and tissue scatter distribution imaging (TSI) for quantification of liver steatosis in patients with nonalcoholic fatty liver disease (NAFLD). We prospectively enrolled 101 participants with suspected NAFLD. The TAI and TSI measurements of the liver were performed with a Samsung RS85 Prestige ultrasound system. Based on the magnetic resonance imaging proton density fat fraction (MRI-PDFF), patients were divided into ≤5%, 5-10%, and ≥10% of MRI-PDFF groups. We determined the correlation between TAI, TSI, and MRI-PDFF and used multiple linear regression analysis to identify any association with clinical variables. The diagnostic performance of TAI, TSI was determined based on the area under the receiver operating characteristic curve (AUC). The intraclass correlation coefficient (ICC) was calculated to assess interobserver reliability. Both TAI (rs = 0.78, P

Cite

CITATION STYLE

APA

Ronaszeki, A. D., Budai, B. K., Csongrady, B., Stollmayer, R., Hagymasi, K., Werling, K., … Kaposi, P. N. (2022). Tissue attenuation imaging and tissue scatter imaging for quantitative ultrasound evaluation of hepatic steatosis. Medicine (United States), 101(33), E29708. https://doi.org/10.1097/MD.0000000000029708

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free